None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Participant is in general good health and has both eyes. 2.Understand the test procedures and agree to adhere to study requirements, instructions and procedures. 3.Males and Females (non-pregnant/non-lactating). 4.Ages 18-45 years both inclusive. 5.Females who wears eye makeup. 6.The study general eye evaluation as assessed by trained clinicians. 7.Pass an eye sting evaluation using isotonic saline. 8.Study participants are willing to refrain from using any eye drops on the day of the study.
Exclusion criteria
Exclusion criteria: 1.Currently or within the last 2 weeks using eye drops (such as saline solutions, Netra-Prabha, Drasty, etc). 2.Have worn contact lenses during the study period. (12 months). 3.Have any of the following conditions or factors that may affect the interpretation of the test results, including but not limited to, diabetes (controlled or uncontrolled), currently pregnant, or currently lactating or have lactated within the last 4 months. 4.Have participated in a study with the eyes as the target area within 6 weeks of the start of the study. 5.Be participating in any other study concurrently. 6.Be involved in any aspect of study administration, i.e., evaluating applying products, etc. 7.Have a history of sensitivity and/or adverse reactions to preparations intended for the eyes. 8.Ever had any eye conditions such as glaucoma, cataracts, exophthalmos (protuberance of the eye), etc. 9.Subject currently having any eye infections or irritation. 10.The subject is having any sensitivity to eye make-up. 11.Currently have any eye infections or irritation including blepharitis, general lid inflammation, conjunctivitis, or an eye discharge within two weeks of the study. 12.Ever had any eye surgery (including Lasik, laser eye surgery). 13.Currently using any topical medications on the face or any medications intended for the eyes. 14.Consume any alcoholic beverages during the days of the study. 15.Have taken antihistamines (including those in cold tablets, OTC allergy medications, decongestants and inhalants) or analgesics (including aspirin or other over-the-couter analgesics) on the days of the study. 16.Have any other condition or factor that the Investigator or Ophthalmologist believes may affect the stinging or tearing response or the interpretation of the results. 17.Currently taking any prescription pain medications. 18.Have smoked within 1 hour before each study visit or during the study visit
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To assess the irritation and stinging/discomfort effect of the test product as comparedto control with both subjective sting/irritation and objective evaluations. 2.To assess the visual effect i.e., degree of inflammation of bulbar conjunctiva, palpebralconjunctiva, and lacrimation of test product as compared with the control. 3.To evaluate the effectiveness of the test product in subject perception questionnaireTimepoint: Day 01, 07 and 15 | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
NovoBliss Research Private Limited